Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9156
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 65 $375,281 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $375,281 Current and potential, with all options
- Last date to order 11% complete
- IDV ceiling 8% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
This IDC was awarded under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The solicitation, expected to be issued in March 2024, will be an unrestricted, lowest price technically acceptable acquisition with a 30-month base period and three 30-month option periods, valued at an estimated $30.3 billion in total. The contract will ensure pharmaceutical supply chain resilience by having at least three different regional primary suppliers as well as a dedicated backup supplier.
Task orders
Show 40 more
Latest 50 of 65 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9156?
SPE2DR25D9156 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DR25D9156 worth?
Orders under SPE2DR25D9156 have obligated $375,281. SPE2DR25D9156's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9156?
65 orders have been placed under SPE2DR25D9156, the latest on July 27, 2026.
Who can order from contract SPE2DR25D9156?
SPE2DR25D9156 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9156 competed?
The extent of competition for SPE2DR25D9156 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV